Stock Analysis on Net
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Debt to Equity
since 2005

Microsoft Excel

Calculation

Amgen Inc., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Total debt1 ÷ Stockholders’ equity1
Dec 31, 2023 10.37 = 64,613 ÷ 6,232
Dec 31, 2022 10.64 = 38,945 ÷ 3,661
Dec 31, 2021 4.97 = 33,309 ÷ 6,700
Dec 31, 2020 3.51 = 32,986 ÷ 9,409
Dec 31, 2019 3.09 = 29,903 ÷ 9,673
Dec 31, 2018 2.71 = 33,929 ÷ 12,500
Dec 31, 2017 1.40 = 35,342 ÷ 25,241
Dec 31, 2016 1.16 = 34,596 ÷ 29,875
Dec 31, 2015 1.12 = 31,556 ÷ 28,083
Dec 31, 2014 1.19 = 30,715 ÷ 25,778
Dec 31, 2013 1.45 = 32,128 ÷ 22,096
Dec 31, 2012 1.39 = 26,529 ÷ 19,060
Dec 31, 2011 1.13 = 21,428 ÷ 19,029
Dec 31, 2010 0.56 = 13,362 ÷ 23,944
Dec 31, 2009 0.47 = 10,601 ÷ 22,667
Dec 31, 2008 0.50 = 10,176 ÷ 20,386
Dec 31, 2007 0.63 = 11,177 ÷ 17,869
Dec 31, 2006 0.48 = 9,012 ÷ 18,964
Dec 31, 2005 0.19 = 3,957 ÷ 20,451

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Amgen Inc., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Amgen Inc. AbbVie Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2023 10.37 5.73 1.35 0.34 2.34 1.09 0.43 0.93 0.04 0.81 0.10 0.75
Dec 31, 2022 10.64 3.67 1.27 0.39 1.52 1.19 0.52 0.67 0.06 0.37 0.12 0.78
Dec 31, 2021 4.97 4.98 1.24 0.49 1.88 1.27 0.46 0.87 0.05 0.50 0.14 0.85
Dec 31, 2020 3.51 6.58 1.34 0.53 2.94 1.73 0.56 1.26 0.05 0.63 0.24 0.63
Dec 31, 2019 3.09 — 0.91 0.72 5.88 1.09 0.47 1.02 0.03 0.83 0.06 0.60
Dec 31, 2018 2.71 — 0.52 0.35 1.30 1.28 0.51 0.94 0.03 0.66 0.08 0.69
Dec 31, 2017 1.40 7.33 0.68 0.40 1.18 1.64 0.57 0.71 — 0.60 0.11 0.83
Dec 31, 2016 1.16 7.95 0.41 0.53 0.74 1.39 0.39 0.62 — 0.71 0.11 0.77
Dec 31, 2015 1.12 8.03 0.47 0.54 0.55 1.20 0.28 0.59 — 0.60 0.10 0.59
Dec 31, 2014 1.19 8.62 0.53 0.15 0.52 0.80 0.27 0.44 — 0.51 0.18 0.71
Dec 31, 2013 1.45 3.28 0.55 0.16 0.30 0.58 0.25 0.50 — 0.48 0.26 0.62
Dec 31, 2012 1.39 4.66 0.54 0.28 0.37 0.88 0.25 0.39 — 0.46 0.37 0.46
Dec 31, 2011 1.13 — 0.34 0.31 0.52 1.13 0.34 0.32 — 0.47 0.90 0.47
Dec 31, 2010 0.56 — 0.35 0.21 0.56 0.59 0.30 0.33 — 0.50 0.31 0.14
Dec 31, 2009 0.47 — 0.43 0.25 0.70 0.18 0.29 0.30 — 0.54 0.27 0.14
Dec 31, 2008 0.50 — 0.55 0.27 1.55 0.31 0.28 0.33 — 0.30 0.00 0.14
Dec 31, 2007 0.63 — 0.59 0.41 0.37 0.38 0.22 0.32 — 0.20 0.43 0.15
Dec 31, 2006 0.48 — 0.74 0.37 0.34 0.77 0.17 0.39 — 0.11 0.92 0.19
Dec 31, 2005 0.19 — 0.77 0.21 0.60 0.10 0.07 0.45 — 0.27 1.75 0.21

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Amgen Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Amgen Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2023 10.37 0.98
Dec 31, 2022 10.64 0.79
Dec 31, 2021 4.97 0.92
Dec 31, 2020 3.51 1.14
Dec 31, 2019 3.09 1.10
Dec 31, 2018 2.71 0.94
Dec 31, 2017 1.40 0.88
Dec 31, 2016 1.16 0.79
Dec 31, 2015 1.12 0.68
Dec 31, 2014 1.19 0.55
Dec 31, 2013 1.45 0.52
Dec 31, 2012 1.39 0.51
Dec 31, 2011 1.13 0.46
Dec 31, 2010 0.56 0.39
Dec 31, 2009 0.47 0.39
Dec 31, 2008 0.50 0.37
Dec 31, 2007 0.63 0.30
Dec 31, 2006 0.48 0.25
Dec 31, 2005 0.19 0.29

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Amgen Inc., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Amgen Inc. Health Care
Dec 31, 2023 10.37 0.81
Dec 31, 2022 10.64 0.72
Dec 31, 2021 4.97 0.78
Dec 31, 2020 3.51 0.90
Dec 31, 2019 3.09 0.91
Dec 31, 2018 2.71 0.87
Dec 31, 2017 1.40 0.79
Dec 31, 2016 1.16 0.75
Dec 31, 2015 1.12 0.68
Dec 31, 2014 1.19 0.52
Dec 31, 2013 1.45 0.49
Dec 31, 2012 1.39 0.51
Dec 31, 2011 1.13 0.45
Dec 31, 2010 0.56 0.41
Dec 31, 2009 0.47 0.41
Dec 31, 2008 0.50 0.41
Dec 31, 2007 0.63 0.36
Dec 31, 2006 0.48 0.33
Dec 31, 2005 0.19 0.30

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).